U.S. Trials for Alzheimer’s “Seaweed Drug” Oligomannate Are Recruiting Participants Being Patient, 08 Mar 2021 The Alzheimer’s Drug, Oligomannate, approved in China and derived from seaweed, is now being studied in the U.S. in a Phase 3…